Lam Research Corporation $LRCX Stock Position Raised by Lingohr Asset Management GmbH

Lingohr Asset Management GmbH lifted its position in Lam Research Corporation (NASDAQ:LRCX) by 590.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 59,555 shares of the semiconductor company’s stock after buying an additional 50,933 shares during the quarter. Lam Research comprises 1.9% of Lingohr Asset Management GmbH’s investment portfolio, making the stock its 13th largest holding. Lingohr Asset Management GmbH’s holdings in Lam Research were worth $7,974,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in Lam Research during the second quarter valued at about $27,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research in the second quarter worth about $29,000. Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter worth about $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research during the 2nd quarter valued at about $31,000. Institutional investors own 84.61% of the company’s stock.

Analyst Ratings Changes

LRCX has been the topic of several analyst reports. Morgan Stanley increased their price target on Lam Research from $211.00 to $244.00 and gave the company an “equal weight” rating in a report on Thursday. BNP Paribas Exane boosted their target price on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Dbs Bank raised their price target on Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Citic Securities boosted their price objective on Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday. Finally, UBS Group set a $300.00 target price on Lam Research in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $238.32.

Insider Buying and Selling

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 41,408 shares of company stock valued at $6,248,501. 0.31% of the stock is currently owned by insiders.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $233.46 on Friday. The firm has a market capitalization of $293.23 billion, a PE ratio of 47.84, a PEG ratio of 3.05 and a beta of 1.77. The company has a current ratio of 2.26, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $251.87. The business’s 50 day moving average is $187.29 and its 200-day moving average is $146.02.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. During the same quarter in the previous year, the company earned $0.91 earnings per share. The business’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Wednesday, December 3rd. Lam Research’s payout ratio is presently 21.31%.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
• Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
• Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
• Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
• Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
• Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.